• Kathryn M Jan, Shweta Mohapatra, and Tiffany S Moon.
• Department of Anesthesiology & Pain Management, UT Southwestern Medical Center, Dallas, Texas, USA.
• Curr Opin Anaesthesiol. 2023 Apr 1; 36 (2): 153158153-158.

Purpose Of ReviewHemorrhage and trauma-induced coagulopathy cause significant morbidity and mortality in trauma patients. Although blood products are the cornerstone of resuscitation, these resources are scarce, necessitating alternatives. This review examines the use of alternative blood products in trauma as well as the literature supporting their use.Recent FindingsThere is no single true blood product alternative. In recent years, there has been great progress in understanding trauma-induced pathophysiology and blood component alternatives. Products such as tranexamic acid and prothrombin complex concentrate have become well established and are frequently utilized in trauma centers, and many more alternatives are still undergoing further research and development.SummaryStabilization of hemorrhage and resuscitation is priority in trauma-induced coagulopathy treatment. Alternative products such as tranexamic acid, recombinant factors, prothrombic complex concentrate, fibrinogen concentrates, and desmopressin may also be considered based on the clinical context. Viscoelastic hemostatic assays such as rotational thromboelastometry and thromboelastography can help guide these efforts. Following initial stabilization, additional interventions such as iron supplementation, erythropoietin stimulating agents, and vitamin D may help with chronic sequela.Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

27 keywords...

hide…